Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

18 October 2024: Clinical Research  

Serum Albumin-to-Creatinine Ratio Predicts One-Year Mortality in Elderly Patients with Non-ST-Elevation Acute Coronary Syndrome After Percutaneous Coronary Intervention: A Prospective Cohort Analysis

Jun-jie Long1ABCDEF, Zhi-gao Wen1ABCDEF, Xiao-jiao Zhang2ABCEFG*

DOI: 10.12659/MSM.945516

Med Sci Monit 2024; 30:e945516

0 Comments

Abstract

0:00

BACKGROUND: Recently, the albumin-to-creatinine ratio (ACR) has been suggested as a valuable biomarker for adverse events in acute myocardial infarction. However, the prognostic value of ACR in very elderly patients (≥80 years) with non-ST-elevation acute coronary syndrome (NSTE-ACS) after percutaneous coronary intervention (PCI) remains unclear.

MATERIAL AND METHODS: A total of 354 very elderly patients with NSTE-ACS who underwent PCI were included in this study and followed up for 1 year. Patients were divided into 3 groups according to ACR tertiles. Logistic regression analysis proportional hazard model was used to determine the prognostic value of ACR.

RESULTS: Sixty-two patients (17.5%) with 114 major adverse cardiovascular and cerebrovascular events (MACCEs) were recorded during 1-year follow-up. Patients with lower ACR tended to be older and had a lower serum albumin level and higher uric acid and creatinine levels (P<0.05). Moreover, patients with lower ACR levels had elevated all-cause mortality and MACCEs. Kaplan-Meier analysis suggested that patients with a lower ACR had a significantly lower survival rate free of all-cause mortality and MACCEs. Multivariable logistic regression analysis demonstrated that ACR was an independent predictor of all-cause mortality in these patients. ROC analysis showed that when ACR was ≤42.8, sensitivity and specificity were 75.2% and 80.2%, respectively, and the area under the ROC curve was 0.802 (95% CI: 0.745-0.859; P<0.001).

CONCLUSIONS: A lower ACR was associated with a higher incidence of all-cause mortality in very elderly patients with NSTE-ACS after PCI. The ACR is a promising indicator for risk stratification and prognostic assessment in these individuals.

Keywords: acute coronary syndrome, Cardiovascular Diseases, Mortality

Introduction

Acute coronary syndrome (ACS), a critical subtype of cardiovascular disease, is a leading cause of morbidity and mortality worldwide [1]. Despite rapid progress in optimal medical treatment, advanced interventional techniques, and well-controlled cardiovascular risk factors, the prognosis of ACS remains unsatisfactory in some cases [2]. As one of the most important risk factors for ACS, aging has been suggested to be associated with poor prognosis in non-ST elevated ACS (NSTE-ACS) [3]. Previous studies have discovered that one-third of hospitalized patients with ACS and two-thirds of patients who died from ACS were over 75 years of age [4,5]. In contrast to younger patients, elderly patients tend to have more complicated comorbidities, more severe coronary lesions, a higher incidence of frailty, and an increased risk of major adverse cardiovascular and cerebrovascular events (MACCEs) [3]. Moreover, patients with NSTE-ACS have a higher incidence of mortality than do patients with ST-elevated myocardial infarction (STEMI), which is attributed to the increased incidence of multivessel disease, more complicated lesion characteristics, and delayed revascularization therapy [6,7]. Therefore, identification of other potential risk factors and their prognostic value is important for the management of these individuals.

A previous study suggested that elderly patients with ACS tend to have a higher incidence of poor renal function [8,9]. Poor renal function is associated with less optimal medical treatment, less frequent selection for PCI, and poor cardiovascular risk management [10]. Moreover, poorer renal function has been associated with an elevated incidence of multivessel and complex lesions [11]. Similar to previous cardiovascular factors, poor renal function has been suggested as an independent predictor of MACCEs, including short- and long-term mortality in elderly patients with ACS [8,9,12]. Serum albumin, the most abundant protein, has been shown to relate to the role of anti-inflammatory and antiplatelet aggregation [13,14]. A lower serum albumin level is associated with an increased risk of mortality in patients [15]. Combining serum albumin with creatinine, the albumin-to-creatinine ratio (ACR) has been shown to be a reliable indicator of poor prognosis in STEMI after primary PCI [16]. However, to date, no studies have focused on the effect of ACR on mortality in elderly patients with NSTE-ACS. More importantly, ACR can be affected by various indicators, including age, sex, and other comorbidities. Therefore, we aimed to explore the relationship between ACR and all-cause mortality in very elderly patients with NSTE-ACS to improve risk stratification and management of these patients.

Material and Methods

STUDY POPULATION:

This was a prospective, observational study. A total of 424 very elderly patients (≥80 years) with NSTE-ACS who underwent PCI between March 2018 and November 2022 were included. A flowchart including the inclusion and exclusion criteria is presented in Figure 1. All patients received follow-up every month after discharge via a telephone call, outpatient visit, re-admission, or WeChat. A total of 40 patients met the exclusion criteria, and 30 were lost to follow-up. Ultimately, 354 elderly patients with NSTE-ACS were included in this study. Since ACR was not normally distributed, the enrolled patients were divided into 3 groups according to the ACR tertiles. Clinical indicators and MACCEs, including all-cause mortality, were recorded for all individuals. This study was performed in accordance with the principles of the Declaration of Helsinki. All patients provided informed consent before participating in the study.

CLINICAL, LABORATORY, AND PROCEDURAL DATA ASSESSMENTS AND DEFINITIONS:

Clinical and procedural characteristics were acquired from the hospital information system and the central imaging laboratory. The ACR was calculated and used as an indicator for the assessment of 1-year prognosis. All the laboratory parameters were acquired from the core laboratory of our hospital. All the angiography and PCI were performed by experienced physicians with relatively high PCI volumes, following the latest guidelines [17]. All the patients received complete revascularization in the hospital or on their next readmission. The coronary lesion characteristics were recorded in detail. The infarct-related artery was identified by interventional cardiologists. If there was a dispute, a second expert was consulted for determination. Totally and subtotally occluded vessels or thrombolysis in myocardial infarction (MI) flow ≤2 grade are usually considered infarct-related arteries [18]. In some cases, intravascular ultrasound, optical coherence tomography, or fractional flow reserve was performed to determine the real infarct-related artery.

FOLLOW-UP AND ENDPOINTS:

The primary endpoint was the all-cause mortality rate. The second endpoint was MACCEs, defined as a composite of all-cause death, target vessel revascularization (TVR), acute myocardial infarction (AMI), and ischemic stroke. The fourth universal definition of AMI was used for diagnosis [19]. TVR was defined as the revascularization of any previous infarct-related artery or its main branches [20]. Monthly follow-up was conducted via WeChat, telephone calls, re-admission, or outpatient visits.

STATISTICAL ANALYSIS:

SPSS version 20.0 (IBM Corp, Armonk, NY, USA) was used for statistical analysis. The patients were divided into 3 groups according to ACR: tertile 1 (n=118, ACR ≤38.5), tertile 2 (n=118, ACR 38.5–49.4), and tertile 3 (n=118, ACR ≥49.4). Categorical variables are shown as rates or percentages and were analyzed using the chi-squared test or Fisher exact test. Normally distributed continuous variables are presented as mean±standard deviation; otherwise, they are presented as median (interquartile range) for a non-normal distribution. Data were analyzed using one-way ANOVA and the Kruskal-Wallis test. The factors associated with all-cause mortality or MACCE in very elderly patients undergoing PCI for NSTE-ACS were explored using univariate analysis. Related factors were included in the logistic regression analysis to investigate the independent predictors of all-cause mortality or MACCEs in very elderly patients with NSTE-ACS after PCI. Receiver operating characteristic (ROC) curves were used to explore the prognostic value of ACR for all-cause mortality and MACCEs. Kaplan-Meier curves and log-rank tests were used to compare survival rates free of mortality or MACCEs among the 3 groups. All tests were 2-sided, and statistical significance was set at P<0.05.

Results

BASELINE AND CLINICAL CHARACTERISTICS:

A total of 354 patients with NSTE-ACS who underwent PCI between March 2018 and November 2022 in our hospital were consecutively included. The flowchart of the study is presented in Figure 1. Clinical parameters, laboratory characteristics, and procedural presentations are shown in Table 1. The included patients were divided into 3 groups according to ACR: tertile 1 (n=118, ACR ≤38.5), tertile 2 (n=118, ACR 38.5–49.4), and tertile 3 (n=118, ACR ≥49.4). The following factors were similar among the 3 groups: cardiovascular risk factors (smoking, diabetes mellitus, and hypertension), medical history (previous heart failure, stroke, MI, and PCI), proportions of non-ST-elevation myocardial infarction and unstable angina, target lesion, lesion characteristics, and medications (all P>0.05). Other indicators, including sex, fasting blood glucose, total cholesterol, triglyceride, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol (LDL-C), NT-proBNP, and left ventricular ejection fraction, were also comparable among the 3 groups (P>0.05). However, patients with a lower ACR had an advanced age, decreased albumin level, and increased uric acid and creatinine levels (P<0.05; Table 1).

INCIDENCE OF CLINICAL OUTCOMES IN THE OVERALL POPULATION DURING 1-YEAR FOLLOW-UP:

The incidence rates of all-cause mortality and MACCE are presented in Table 2. A total of 62 patients died during the 1-year follow-up, and MACCEs developed in 41.5% (49/118) of the tertile 1 group, 34.7% (41/118) of the tertile 2 group, and 20.3% (24/118) of the tertile 3 group. The incidences of TVR, AMI, and stroke were comparable among the 3 groups. However, compared with those with higher ACR, patients with lower ACR showed an elevated incidence of all-cause mortality (22.9% vs 17.8% vs 8.5%, respectively; P=0.010) and MACCEs (41.5% vs 34.7% vs 20.3%, respectively; P=0.002; Table 2). Kaplan-Meier analysis showed that patients with a lower ACR tended to have a poor clinical outcome, defined as survival free of mortality and MACCEs, which was statistically significant (Figure 2A, 2B).

FACTORS ASSOCIATED WITH MORTALITY:

Univariate analysis showed that age, LDL-C level, uric acid level, and ACR were associated with all-cause mortality in very elderly patients with NSTE-ACS after PCI. The logistic regression model revealed that ACR was an independent predictor of all-cause mortality in the elderly patients with NSTE-ACS after PCI (Table 3). ROC analysis showed that when ACR was ≤42.8, the sensitivity and specificity were 75.2% and 80.2%, respectively, and the area under the ROC curve (AUC) was 0.802 (95% CI: 0.745–0.859; P<0.001; Figure 3). By combining creatinine and albumin values, ACR provided a better predictive value for all-cause mortality in the very elderly patients with NSTE-ACS after PCI than creatinine or albumin values alone (P<0.001; Figure 3).

Discussion

LIMITATIONS:

This study had some limitations. First, we measured ACR only on admission; we did not collect data on ACR continuously and dynamically in the hospital and during follow-up. Second, although we tried to include all the potential indicators in the statistical analysis, some of the factors can still be missing. Third, we included only very elderly patients with low serum creatinine levels; therefore, the results could not be extended to other populations. Fourth, 7.8% of the patients were lost during the follow-up, which was a relatively high percentage. It is estimated that the incidence of outcomes and adverse events can be even higher in patients lost to follow-up; therefore, this introduces a significant study bias. Finally, this was an observational study with a relatively small sample size, especially in the subgroup analysis. Further studies are required to confirm these results.

Conclusions

In the present study, we discovered that a lower ACR was an independent predictor for all-cause mortality in very elderly individuals with NSTE-ACS after PCI. Moreover, ROC analysis showed that ACR provided a better prognostic value than albumin or creatinine levels alone. As an easy acquired indicator in clinical practice, the ACR can serve as a promising indicator for risk stratification and prognostic assessment in these patients. Further investigation is needed to determine whether the ACR could improve the predictive value of established indicators, such as the Global Registry of Acute Coronary Events score.

References

1. Bergmark BA, Mathenge N, Merlini PA, Acute coronary syndromes: Lancet, 2022; 399(10332); 1347-58

2. Jernberg T, Hasvold P, Henriksson M, Cardiovascular risk in post-myocardial infarction patients: Nationwide real world data demonstrate the importance of a long-term perspective: Eur Heart J, 2015; 36(19); 1163-70

3. Li Y, Shen J, Hou X, Geriatric nutritional risk index predicts all-cause mortality in the oldest-old patients with acute coronary syndrome: A 10-year cohort study: Front Nutr, 2023; 10; 1129978

4. Kayani WT, Khan MR, Deshotels MR, Jneid H, Challenges and controversies in the management of ACS in elderly patients: Curr Cardiol Rep, 2020; 22(7); 51

5. Jiménez-Méndez C, Díez-Villanueva P, Alfonso F, Non-ST segment elevation myocardial infarction in the elderly: Rev Cardiovasc Med, 2021; 22; 779-86

6. Goldberg RJ, Currie K, White K, Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]): Am J Cardiol, 2004; 93(3); 288-93

7. Chang SS, Lu CR, Chen KW, Prognosis between ST-elevation and non-ST-elevation myocardial infarction in older adult patients: Front Cardiovasc Med, 2022; 8; 749072

8. Huo Y, Van de Werf F, Han Y, Long-term antithrombotic therapy and clinical outcomes in patients with acute coronary syndrome and renal impairment: Insights from EPICOR and EPICOR Asia: Am J Cardiovasc Drugs, 2021; 21(4); 471-82

9. Gao H, Peng H, Shen A, Predictive effect of renal function on clinical outcomes in older adults with acute myocardial infarction: Results from an observational cohort study in China: Front Cardiovasc Med, 2021; 8; 772774

10. Rozenbaum Z, Benchetrit S, Minha S, The effect of admission renal function on the treatment and outcome of patients with acute coronary syndrome: Cardiorenal Med, 2017; 7(3); 169-78

11. Chang RY, Tsai HL, Koo M, Guo HR, Association between renal function impairment and multivessel involvement in patients with acute ST-elevation myocardial infarction: Aging (Albany NY), 2020; 12(11); 10863-72

12. De Rosa R, Morici N, De Servi S, Impact of renal dysfunction and acute kidney injury on outcome in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention: Eur Heart J Acute Cardiovasc Care, 2021; 10(10); 1160-69

13. Soeki T, Sata M, Inflammatory biomarkers and atherosclerosis: Int Heart J, 2016; 57(2); 134-39

14. Çağdaş M, Rencüzoğullari I, Karakoyun S, Assessment of relationship between c-reactive protein to albumin ratio and coronary artery disease severity in patients with acute coronary syndrome: Angiology, 2019; 70(4); 361-68

15. Kurtul A, Murat SN, Yarlioglues M, Usefulness of serum albumin concentration to predict high coronary SYNTAX score and in-hospital mortality in patients with acute coronary syndrome: Angiology, 2016; 67(1); 34-40

16. Huang X, Liu Y, Zhong C, Association between serum albumin-to-creatinine ratio and clinical outcomes among patients with ST-elevation myocardial infarction after percutaneous coronary intervention: A secondary analysis based on Dryad databases: Front Cardiovasc Med, 2023; 10; 1191167

17. Byrne RA, Rossello X, Coughlan JJESC Scientific Document Group, 2023 ESC Guidelines for the management of acute coronary syndromes: Eur Heart J, 2023; 44(38); 3720-26 [Erratum in: Eur Heart J. 2024;45(13):1145]

18. Refaat H, Tantawy A, Gamal AS, Radwan H, Novel predictors and adverse long-term outcomes of No-reflow phenomenon in patients with acute ST elevation myocardial infarction undergoing primary percutaneous coronary intervention: Indian Heart J, 2021; 73(1); 35-43

19. Thygesen K, Alpert JS, Jaffe ASExecutive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction, Fourth Universal Definition of Myocardial Infarction (2018): Circulation, 2018; 138(20); e618-e51 [Erratum in: Circulation. 2018;138(20):e652]

20. Zhao HW, Wang Y, Wang CF, Meng QK, Association between triglyceride glucose index and adverse clinical outcomes in patients with acute myocardial infarction and LDL-C ≤1.8 mmol/L who underwent percutaneous coronary intervention: A prospective cohort study: Front Endocrinol (Lausanne), 2024; 14; 1323615

21. Shlipak MG, Fried LF, Stehman-Breen C, Chronic renal insufficiency and cardiovascular events in the elderly: Findings from the Cardiovascular Health Study: Am J Geriatr Cardiol, 2004; 13(2); 81-90

22. Wang J, Sim AS, Wang XL, Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease: Atherosclerosis, 2008; 197; 853-59

23. Shlipak MG, Ix JH, Bibbins-Domingo K, Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study: Am J Med, 2008; 121(1); 50-57

24. Ma J, Bian S, Gao M, Prediction of outcomes through cystatin C and cTnI in elderly type 2 myocardial infarction patients: Clin Interv Aging, 2023; 18; 1415-22

25. Zhang Y, Zhai G, Wang J, Zhou Y, Risk factors of cardiac death for elderly patients with severe chronic kidney disease after percutaneous coronary intervention: Clin Appl Thromb Hemost, 2022; 28; 10760296221081848

26. Manolis AA, Manolis TA, Melita H, Low serum albumin: A neglected predictor in patients with cardiovascular disease: Eur J Intern Med, 2022; 102; 24-39

27. Chien SC, Chen CY, Leu HB, Association of low serum albumin concentration and adverse cardiovascular events in stable coronary heart disease: Int J Cardiol, 2017; 241; 1-5

28. Bicciré FG, Pastori D, Tanzilli A, Low serum albumin levels and in-hospital outcomes in patients with ST segment elevation myocardial infarction: Nutr Metab Cardiovasc Dis, 2021; 31(10); 2904-11

29. Li X, Zhang Y, He Y, J-shaped association between serum albumin levels and long-term mortality of cardiovascular disease: Experience in National Health and Nutrition Examination Survey (2011–2014): Front Cardiovasc Med, 2022; 9; 1073120

30. Kurtul A, Ocek AH, Murat SN, Serum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: Angiology, 2015; 66(3); 278-85

31. Murat SN, Kurtul A, Yarlioglues M, Impact of serum albumin levels on contrast-induced acute kidney injury in patients with acute coronary syndromes treated with percutaneous coronary intervention: Angiology, 2015; 66(8); 732-37

32. Liu H, Zhang J, Yu J, Prognostic value of serum albumin-to-creatinine ratio in patients with acute myocardial infarction: Results from the retrospective evaluation of acute chest pain study: Medicine (Baltimore), 2020; 99(35); e22049

33. Shen Q, Yao D, Zhao Y, Elevated serum albumin-to-creatinine ratio as a protective factor on outcomes after heart transplantation: Front Cardiovasc Med, 2023; 10; 1210278

In Press

Clinical Research  

Comprehensive Analysis of Immune Infiltration and Key Genes in Peri-Implantitis Using Bioinformatics and Mo...

Med Sci Monit In Press; DOI: 10.12659/MSM.941870  

Clinical Research  

High-Resolution Anorectal Manometry and Balloon Expulsion Test Outcomes in Functional Constipation: A Compa...

Med Sci Monit In Press; DOI: 10.12659/MSM.944599  

Clinical Research  

Plaque Removal and Gingival Bleeding Using Biodegradable Toothbrushes: Salvadora persica, Bamboo, and Nylo...

Med Sci Monit In Press; DOI: 10.12659/MSM.944469  

Clinical Research  

Comparative Analysis of Extended Curettage with Plate Fixation and Extended Curettage with Intramedullary N...

Med Sci Monit In Press; DOI: 10.12659/MSM.945157  

Most Viewed Current Articles

17 Jan 2024 : Review article   6,190,650

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,908,656

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   695,192

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

07 Jan 2022 : Meta-Analysis   260,387

Efficacy and Safety of Light Therapy as a Home Treatment for Motor and Non-Motor Symptoms of Parkinson Dise...

DOI :10.12659/MSM.935074

Med Sci Monit 2022; 28:e935074

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750